These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 914081)

  • 1. Preparation of fibrin monomers from human fibrinogen in urea, using soluble or insolubilized thrombin.
    Brosstad F; Godal HC; Kierulf P
    Haemostasis; 1977; 6(4):225-35. PubMed ID: 914081
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
    Smith GF
    Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
    von Hugo R; Stemberger A; Graeff H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF; Bang NU
    Biochemistry; 1972 Aug; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract]   [Full Text] [Related]  

  • 5. Qualitative changes in fibrinogen following exposure to agents used for preparation of fibrin monomers.
    Brosstad F; Godal HC
    Haemostasis; 1977; 6(3):149-56. PubMed ID: 18381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
    Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG
    Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S; Yamada K
    Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption of fibrinogen and fragment D of fibrinogen onto the insolubilized alpha-chain of fibrin.
    Matthias FR
    Thromb Haemost; 1979 Jun; 41(4):687-90. PubMed ID: 483242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for aggregation of fibrin fragments D and E in soluble fibrin complex formation.
    Chang ML; Latallo ZS; Bang NU; Mattler LE; Hansen MS
    Thromb Res; 1974 Dec; 5(6):719-34. PubMed ID: 4445994
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding properties on Sepharose insolubilized fibrinogen and fibrin, of various species of fibrinogen and fibrin solubilized in plasma.
    Nilsen DW; Holm B; Brosstad F
    Thromb Res; 1986 May; 42(4):449-59. PubMed ID: 3715811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of various thrombin fractions to fibrin and the influence of AT-III on their adsorption.
    Nilsen DW; Brosstad F; Kierulf P; Godal HC
    Thromb Haemost; 1986 Jun; 55(3):352-6. PubMed ID: 3750265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and insolubilization of reptilase for the preparation of human des-AA fibrin monomers in urea.
    Brosstad F; Kierulf P; Gravem K; Godal HC
    Thromb Res; 1978 Nov; 13(5):715-23. PubMed ID: 741447
    [No Abstract]   [Full Text] [Related]  

  • 16. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some symmetry considerations for the fibrinogen-fibrin assembly system.
    Doolittle RF
    J Supramol Struct; 1974; 2(2-4):138-49. PubMed ID: 4474572
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.